Teva's generics and biosimilars fuel another booming quarter kdunleavy Wed, 11/06/2024 - 15:00
After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy fkansteiner Wed, 11/06/2024 - 14:08
More M&A, or a shake-up at the FDA? Pharma braces for Trump's return to the White House zbecker Wed, 11/06/2024 - 11:17
Novavax coughs up $123.8M to settle COVID vaccine supply dispute with UK aliu Wed, 11/06/2024 - 09:49
Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report kdunleavy Wed, 11/06/2024 - 09:23
Analysts point to Syfovre 'nadir' after Apellis discloses disappointing quarter fkansteiner Tue, 11/05/2024 - 15:00
Vytvorte si vlastný informačný kanál
Ste pripravení to vyskúšať?
Začnite 14-dňovú skúšobnú verziu, kreditná karta sa nevyžaduje.